Page 8 - ஆரம் ஆரோக்கியம் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆரம் ஆரோக்கியம் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆரம் ஆரோக்கியம் இன்க் Today - Breaking & Trending Today

Radius Health, Inc. Announces Acquisition of Orphan Disease Program

Published: Jan 06, 2021
RAD011 is a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseases
Prader-Willi syndrome (“PWS”) will be the initial indication, which has been granted Orphan Drug and Fast Track Designation by the FDA
Acquisition and associated PWS trial costs to be funded from existing operations
Management to host conference call and webcast this morning at 8:15 a.m. ET
BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE)
Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced a definitive agreement to acquire the global development and commercialization rights to
Benuvia Therapeutics Inc.’s (“Benuvia”) synthetic cannabidiol oral solution (“RAD011”). The Company plans to initiate a pivotal Phase 2/3 study for patients with Prader-Willi syndrome (“PWS”) in the second half of 2021 pending regulatory discussion with the U.S. ....

United States , Peter Schwartzman , Kelly Martin , Julie Ferguson , Toddc Davis , Benuvia Therapeutics Inc , Company Nasdaq , Jp Morgan Securities , Foundation For Prader Willi Research , Drug Administration , Research Development , Ropes Gray , Exchange Commission , Radius Health , Radius Health Inc , Orphan Drug , Fast Track Designation , Benuvia Therapeutics , Radius Chief Executive Officer , Benuvia Manufacturing , Rady Children , Prader Willi Syndrome Clinic , Prader Willi Research , Orphan Drug Designation , Private Securities Litigation Reform Act , Annual Report ,

Is VNDA A Good Stock To Buy Now According To Hedge Funds?

Is VNDA A Good Stock To Buy Now According To Hedge Funds?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as to maintain the desired risk profile. As a result, the relevancy of these public filings and their content is indisputable, as they may reveal numerous high-potential stocks. The following article will discuss the smart money sentiment towards Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). ....

Benjamina Smith Laurion , William Leland Edwards Palo , Israel Englander , William Leland Edwards , Donald Sussman Paloma , Vanda Pharmaceuticals Inc , Electronics Inc , Ken Griffin Citadel Investment Group , Mitek Systems Inc , Aptose Biosciences Inc , Hycroft Mining Holding Corporation , Federal Reserve , Yintech Investment Holdings Limited , Radius Health Inc , Insider Monkey , Vanda Pharmaceuticals , Leland Edwards , Palo Alto , Good Stock To Buy , Steven Boyd , Armistice Capital , Renaissance Technologies , Palo Alto Investors , Ken Griffin , Citadel Investment Group , Millennium Management ,